RISK AND INCIDENCE OF INTRACRANIAL HEMORRHAGE ASSOCIATED WITH ORAL ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION

被引：0
|
作者：
Abdelnabi, M. [1 ]
Saleh, Y. [2 ]
Badran, H. [3 ]
Almaghraby, A. [4 ]
机构：
[1] Alexandria Univ, Med Res Inst, Cardiol & Angiol Unit, Clin & Expt Internal Med, Alexandria, Egypt
[2] Houston Methodist, Cardiol Dept, Houston, TX USA
[3] Ain Shams Univ, Fac Med, Cardiol Dept, Cairo, Egypt
[4] Alexandria Univ, Fac Med, Cardiol Dept, Alexandria, Egypt
来源：
ATHEROSCLEROSIS | 2021年 / 331卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P531
引用
收藏
页码：E225 / E225
页数：1
相关论文
共 50 条
  • [1] Incidence, Mortality, and Risk Factors for Oral Anticoagulant-associated Intracranial Hemorrhage in Patients with Atrial Fibrillation
    Grysiewicz, Rebbeca
    Gorelick, Philip B.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (10): : 2479 - 2488
  • [2] Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation
    Luca, Fabiana
    Colivicchi, Furio
    Oliva, Fabrizio
    Abrignani, Maurizio
    Caretta, Giorgio
    Di Fusco, Stefania Angela
    Giubilato, Simona
    Cornara, Stefano
    Di Nora, Concetta
    Pozzi, Andrea
    Di Matteo, Irene
    Pilleri, Anna
    Rao, Carmelo Massimiliano
    Parlavecchio, Antonio
    Ceravolo, Roberto
    Benedetto, Francesco Antonio
    Rossini, Roberta
    Calvanese, Raimondo
    Gelsomino, Sandro
    Riccio, Carmine
    Gulizia, Michele Massimo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [3] Warfarin therapy in patients with atrial fibrillation: risk of intracranial hemorrhage
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 (1): : 6 - 6
  • [4] Risk of osteoporosis in patients with atrial fibrillation with and without oral anticoagulant therapy
    Bezabhe, Woldesellassie M.
    Radford, Jan
    Wimmer, Barbara C.
    Salahudeen, Mohammed S.
    Bindoff, Ivan
    Ling, Tristan
    Peterson, Gregory M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (08) : 1003 - 1010
  • [5] Development and Validation of an Intracranial Hemorrhage Risk Score in Older Adults with Atrial Fibrillation Treated with Oral Anticoagulant
    Bessette, Lily G.
    Singer, Daniel E.
    Pawar, Ajinkya
    Wong, Vincent
    Kim, Dae Hyun
    Lin, Kueiyu Joshua
    CLINICAL EPIDEMIOLOGY, 2024, 16 : 267 - 279
  • [6] Development and Validation of an Intracranial Hemorrhage Risk Score in Older Adults with Atrial Fibrillation Treated with Oral Anticoagulant
    Bessette, L. G.
    Singer, D.
    Pawar, A.
    Wong, V.
    Kim, D.
    Lin, K. J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S12 - S12
  • [7] Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy
    Rivera-Caravaca, Jose Miguel
    Esteve-Pastor, Maria Asuncion
    Camelo-Castillo, Anny
    Ramirez-Macias, Inmaculada
    Lip, Gregory Y. H.
    Roldan, Vanessa
    Marin, Francisco
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (15) : 1867 - 1881
  • [8] Rivaroxiban associated intracranial hemorrhage in atrial fibrillation patients
    Alkhotani, A.
    Alrishi, N.
    Alzahrani, W.
    Alharthi, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [9] Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused Review
    Arbit, Boris
    Hsu, Jonathan C.
    CLINICAL CARDIOLOGY, 2015, 38 (11) : 684 - 691
  • [10] Oral anticoagulant therapy for patients with atrial fibrillation - an update
    Hylek, Elaine M.
    THROMBOSIS RESEARCH, 2008, 123 : S46 - S49
12345